SciCombinator

Discover the most talked about and latest scientific content & concepts.

A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine

OPEN The New England journal of medicine | 15 Nov 2013

LF Fries, GE Smith and GM Glenn
Abstract
To the Editor: Avian-origin influenza A (H7N9) viruses emerged as human pathogens in China in 2013 and have caused 137 cases and 45 deaths to date.(1) These viruses have acquired mutations that could facilitate infection in mammals,(2) which could pose a pandemic threat if the viruses become readily transmissible in humans. Vaccines are a key defense against pandemics, but candidate vaccines featuring H7 hemagglutinins (HA) have been poorly immunogenic.(3) We have previously described the development, manufacture, and efficacy in mice of an A/Anhui/1/13 (H7N9) viruslike particle (VLP) vaccine produced in insect cells with the use of recombinant baculovirus. This vaccine . . .
Tweets*
61
Facebook likes*
5
Reddit*
0
News coverage*
68
Blogs*
0
SC clicks
0
Concepts
Vaccination, Influenza vaccine, Pandemic, Vaccine, Immune system, Influenza pandemic, Microbiology, Influenza
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com